Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of mortality in patients on chemotherapy or immunotherapy during and before COVID-19 pandemic. Multicenter matched cohort study in Argentina.
Itkin B, Straminsky S, Cáceres H, Onassis M, García AE, Avanzi L, Kaminszczik L, Serna Sejas R, Rapaccioli M, Billordo G, Lavaccara D, Lanzavecchia J, Gibbons L, Settecase E, Bardach A. Itkin B, et al. Among authors: avanzi l. Rev Peru Med Exp Salud Publica. 2023 Apr-Jun;40(2):161-169. doi: 10.17843/rpmesp.2023.402.12519. Rev Peru Med Exp Salud Publica. 2023. PMID: 38232262 Free PMC article.
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
Liu Z, Le K, Zhou X, Alexander JL, Lin S, Bewshea C, Chanchlani N, Nice R, McDonald TJ, Lamb CA, Sebastian S, Kok K, Lees CW, Hart AL, Pollok RC, Boyton RJ, Altmann DM, Pollock KM, Goodhand JR, Kennedy NA, Ahmad T, Powell N; CLARITY study investigators. Liu Z, et al. Lancet Gastroenterol Hepatol. 2023 Feb;8(2):145-156. doi: 10.1016/S2468-1253(22)00389-2. Epub 2022 Dec 5. Lancet Gastroenterol Hepatol. 2023. PMID: 36481043 Free PMC article.
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.
Kennedy NA, Goodhand JR, Bewshea C, Nice R, Chee D, Lin S, Chanchlani N, Butterworth J, Cooney R, Croft NM, Hart AL, Irving PM, Kok KB, Lamb CA, Limdi JK, Macdonald J, McGovern DP, Mehta SJ, Murray CD, Patel KV, Pollok RC, Raine T, Russell RK, Selinger CP, Smith PJ, Bowden J, McDonald TJ, Lees CW, Sebastian S, Powell N, Ahmad T; Contributors to the CLARITY IBD study. Kennedy NA, et al. Gut. 2021 May;70(5):865-875. doi: 10.1136/gutjnl-2021-324388. Epub 2021 Mar 22. Gut. 2021. PMID: 33753421
Perceptions of the Targets and Sources of COVID-19 Threat are Structured by Group Memberships and Responses are Influenced by Identification with Humankind.
Frenzel SB, Junker NM, Avanzi L, Erkens VA, Haslam SA, Haslam C, Häusser JA, Knorr D, Meyer I, Mojzisch A, Monzani L, Reicher SD, Schuh SC, Steffens NK, van Zyl LE, van Dick R. Frenzel SB, et al. Among authors: avanzi l. Psychol Belg. 2022 Mar 16;62(1):75-88. doi: 10.5334/pb.1043. eCollection 2022. Psychol Belg. 2022. PMID: 35414942 Free PMC article.
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab.
Lin S, Kennedy NA, Saifuddin A, Sandoval DM, Reynolds CJ, Seoane RC, Kottoor SH, Pieper FP, Lin KM, Butler DK, Chanchlani N, Nice R, Chee D, Bewshea C, Janjua M, McDonald TJ, Sebastian S, Alexander JL, Constable L, Lee JC, Murray CD, Hart AL, Irving PM, Jones GR, Kok KB, Lamb CA, Lees CW, Altmann DM, Boyton RJ, Goodhand JR, Powell N, Ahmad T; CLARITY IBD study. Lin S, et al. Nat Commun. 2022 Mar 16;13(1):1379. doi: 10.1038/s41467-022-28517-z. Nat Commun. 2022. PMID: 35296643 Free PMC article.
Identity Leadership, Employee Burnout and the Mediating Role of Team Identification: Evidence from the Global Identity Leadership Development Project.
van Dick R, Cordes BL, Lemoine JE, Steffens NK, Haslam SA, Akfirat SA, Ballada CJA, Bazarov T, Aruta JJBR, Avanzi L, Bodla AA, Bunjak A, Černe M, Dumont KB, Edelmann CM, Epitropaki O, Fransen K, García-Ael C, Giessner S, Gleibs IH, Godlewska-Werner D, González R, Kark R, Laguia Gonzalez A, Lam H, Lipponen J, Lupina-Wegener A, Markovits Y, Maskor M, Molero F, Monzani L, Moriano Leon JA, Neves P, Orosz G, Pandey D, Retowski S, Roland-Lévy C, Samekin A, Schuh S, Sekiguchi T, Song LJ, Story J, Stouten J, Sultanova L, Tatachari S, Valdenegro D, van Bunderen L, Van Dijk D, Wong SI, Youssef F, Zhang XA, Kerschreiter R. van Dick R, et al. Among authors: avanzi l. Int J Environ Res Public Health. 2021 Nov 17;18(22):12081. doi: 10.3390/ijerph182212081. Int J Environ Res Public Health. 2021. PMID: 34831833 Free PMC article.
25 results